Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Vaccine ; 39(41): 6081-6087, 2021 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-34521551

RESUMO

Sustainable demand for seasonal influenza vaccines is a component of national security strategies for pandemic preparedness. However, the ongoing COVID-19 pandemic has revealed many weaknesses in the capacity of countries to design and execute sustainable vaccination programs. An influenza pandemic remains a global threat and yet there is no global monitoring system for assessing progress towards influenza vaccination coverage targets. The International Federation of Pharmaceutical Manufacturers and Associations' (IFPMA) Influenza Vaccine Supply International Task Force (IVS) developed a survey method in 2008 to estimate seasonal influenza vaccination coverage rates, which in turn serves as a crude estimate of pandemic preparedness. It provides evidence to guide expanded efforts for pandemic preparedness, specifically for increasing COVID-19 vaccine immunization levels. Furthermore, the results presented herein serve as a proxy for assessing the state of pandemic preparedness at a global and regional level. This paper adds data from 2018 and 2019 to the previous analyses. The current data show an upward or stable global trend in seasonal influenza vaccine dose distributed per 1,000 population with a 7% increase between 2017 and 2018 and 6% increase between 2018 and 2019. However, considerable regional inequities in access to vaccine persist. Three regions, Africa, the Middle-east, and Southeast Asia together account for 50% of the global population but only 6% of distributed seasonal influenza vaccine doses. This is an important finding in the context of the ongoing COVID-19 pandemic, as distribution of influenza vaccine doses in many ways reflects access to COVID-19 vaccines. Moreover, improving seasonal vaccine uptake rates is critical for optimizing the annual benefits by reducing the huge annual influenza-associated societal burdens and by providing protection to vulnerable individuals against serious complications from seasonal influenza infections.


Assuntos
COVID-19 , Vacinas contra Influenza , Influenza Humana , Vacinas contra COVID-19 , Humanos , Influenza Humana/epidemiologia , Influenza Humana/prevenção & controle , Pandemias , SARS-CoV-2 , Estações do Ano , Vacinação
2.
Health Secur ; 18(3): 241-249, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32348165

RESUMO

The COVID-19 pandemic is a stark reminder of the heavy toll that emerging infectious diseases (EIDs) with epidemic and pandemic potential can inflict. Vaccine development, scale-up, and commercialization is a long, expensive, and risky enterprise that requires substantial upfront planning and offers no guarantee of success. EIDs are a particularly challenging target for global health preparedness, including for vaccine development. Insufficient attention has been given to challenges, lessons learned, and potential solutions to support and sustain vaccine industry engagement in vaccine development for EIDs. Drawing from lessons from the most recent Ebola epidemic in the Democratic Republic of the Congo, as well as the 2009 H1N1 influenza, 2014-2016 Ebola, and 2015-16 Zika outbreaks preceding it, we offer our perspective on challenges facing EID vaccine development and recommend additional solutions to prioritize in the near term. The 6 recommendations focus on reducing vaccine development timelines and increasing business certainty to reduce risks for companies. The global health security community has an opportunity to build on the current momentum to design a sustainable model for EID vaccines.


Assuntos
Doenças Transmissíveis Emergentes/prevenção & controle , Infecções por Coronavirus/prevenção & controle , Saúde Global , Vacinas contra Influenza/farmacologia , Pandemias/prevenção & controle , Pneumonia Viral/prevenção & controle , Tecnologia Farmacêutica/organização & administração , COVID-19 , Controle de Doenças Transmissíveis/organização & administração , Doenças Transmissíveis Emergentes/epidemiologia , Infecções por Coronavirus/epidemiologia , Aprovação de Drogas , Desenvolvimento de Medicamentos , Indústria Farmacêutica/organização & administração , Feminino , Humanos , Vacinas contra Influenza/administração & dosagem , Masculino , Avaliação das Necessidades , Pandemias/estatística & dados numéricos , Pneumonia Viral/epidemiologia , Saúde Pública , Medidas de Segurança
3.
Nurs Stand ; 34(2): 59-65, 2019 01 25.
Artigo em Inglês | MEDLINE | ID: mdl-31468843

RESUMO

Tracheostomy insertion and management is increasingly common in critical care units and general wards. Therefore, it is important that nurses are equipped with the appropriate knowledge and skills to meet the individual needs of patients with a tracheostomy safely and competently. This article aims to enhance nurses' understanding of the potential challenges that patients with a tracheostomy may experience, and to guide nurses in providing effective care and support to these patients. It outlines the care that should be provided for patients with a tracheostomy who are critically ill, including methods of humidification and endotracheal suctioning. This article also discusses the effects that a tracheostomy may have on a patient's communication and psychological well-being, and explains the actions that nurses should take in an emergency and if complications occur.


Assuntos
Estado Terminal , Traqueostomia , Comunicação , Cuidados Críticos , Emergências , Humanos , Unidades de Terapia Intensiva , Avaliação em Enfermagem , Sucção , Traqueostomia/enfermagem
4.
Am J Public Health ; 106(2): 269-70, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26691132

RESUMO

Recent outbreaks of vaccine-preventable diseases in the United States have renewed public discourse about state vaccine mandates for children entering schools. With acknowledgment of the challenge of eliminating religious and philosophical exemptions in most states, some have proposed instead to impose additional administrative burdens for parents seeking such exemptions. We review the use of taxes, fines, and fees as financial disincentives in public health. We argue that adding processing fees to a comprehensive set of administrative requirements for obtaining exemptions will avoid the use of taxpayer funding for exemption processing and will help tilt the balance of convenience in favor of vaccination.


Assuntos
Honorários e Preços/legislação & jurisprudência , Programas de Imunização/legislação & jurisprudência , Instituições Acadêmicas/legislação & jurisprudência , Governo Estadual , Recusa do Paciente ao Tratamento/legislação & jurisprudência , Criança , Humanos , Saúde Pública/legislação & jurisprudência , Religião e Medicina , Impostos , Estados Unidos , Vacinação/legislação & jurisprudência
5.
Am J Law Med ; 42(2-3): 487-523, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-29086636

RESUMO

Antibiotics have prevented countless deaths from common infections and have made possible many modern medical procedures. Over the past few decades, antibiotic-resistant bacteria have become a global threat, spreading between healthcare facilities and throughout communities worldwide at an alarming pace. Antibiotic overuse and misuse in humans, animals, and the environment accelerate resistance by selecting for bacteria with antibiotic-resistant traits, which then become predominant and infect others. Meanwhile, few antibiotics remain active against the most resistant bacteria. There is an urgent need for new antibiotics and other antibacterial products to replace second-line and last resort therapies when they no longer work. This Article proposes a new U.S.-based, non-governmental, not-for-profit product development partnership (PDP) model specifically designed for antibacterial development. This new model should both supplement and complement existing government-led efforts and should be built with mechanisms in place to balance the values of innovation, access, and conservation.


Assuntos
Antibacterianos/farmacologia , Descoberta de Drogas , Resistência Microbiana a Medicamentos , Parcerias Público-Privadas , Humanos
6.
Health Secur ; 13(6): 349-54, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26569379

RESUMO

Antibiotic resistance has been increasing at an alarming rate in the United States and globally for decades, but the problem has only recently gained broad attention at the highest levels of the US government. More and more patients are dying of infections that do not respond to antibiotics that are currently available. Meanwhile, the antibacterial product pipeline remains fragile in part because of a lack of commercial interest from pharmaceutical companies. The Biomedical Advanced Research and Development Authority (BARDA) Broad Spectrum Antimicrobials (BSA) program leads the US government's effort to bridge this gap by advancing new antibacterials through late stages of clinical development. Other commentators have described in detail BARDA's structure, process, and role in antibacterial development. This commentary offers a public policy perspective on the emerging politics of antibiotic resistance in the context of US biosecurity politics and medical countermeasure (MCM) development. It identifies promising developments and difficult challenges that together will ultimately determine whether BARDA can become a global leader for antibiotic development.


Assuntos
Antibacterianos/provisão & distribuição , Resistência Microbiana a Medicamentos , Financiamento Governamental , Humanos , Saúde Pública , Política Pública , Pesquisa/economia , Medidas de Segurança , Estados Unidos
7.
Nurse Educ Pract ; 14(3): 253-8, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24295615

RESUMO

This study describes a qualitative research design that focuses on nursing students who were aligned to different extra-curricular groups (a student representative committee, a Nurses' Day Committee and a magazine editorial team) within the School of Health. The study explores the nursing students' experiences and perceptions of belonging to an extra-curricular group within a pre-registration nursing course. Data were collected using focus groups. The findings of this study suggest that students who are members of extra-curricular groups perceive group membership to have many positive benefits. The findings were grouped into three main themes namely: employability, retention and personal gain. The findings suggest that students are clearly aware of their career development and expressed how group membership meant they were able to develop skills around employability. Students highlighted that they gained support and built lasting relationships through the groups which supported and reassured them which it was felt enabled them to progress successfully through the course. These themes reinforce the value of having established groups within a pre-registration curriculum.


Assuntos
Bacharelado em Enfermagem/métodos , Socialização , Estudantes de Enfermagem/psicologia , Adulto , Atitude do Pessoal de Saúde , Feminino , Grupos Focais , Humanos , Masculino , Motivação , Pesquisa em Educação em Enfermagem , Identificação Social , Adulto Jovem
8.
Nurs Stand ; 26(14): 64, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22259973
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA